The high NKG2A expression level in NK and CD8+ T cell subsets in the tumor microenvironment in OC, together with the high response rate in NKG2A+ traNK cells that we detected in this study, suggest that blocking the NKG2A – HLA-E interaction may be beneficial for patients with OC. This evidence concerns the gene CD8A and neoplasm.